Skip to main content
David Lederer, MD, Pulmonology, Tarrytown, NY, New York-Presbyterian Hospital

DavidJoshuaLedererMDMS

Pulmonology Tarrytown, NY

Interstitial Lung Diseases, Pleural Disease

Medical Director, Clinical Development, Respiratory and Inflammation, Regeneron Pharmaceuticals, Inc.

Dr. Lederer is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lederer's full profile

Already have an account?

Education & Training

  • Columbia University, Mailman School of Public Health
    Columbia University, Mailman School of Public HealthM.S., Biostatistics, 2005 - 2007
  • New York Presbyterian Hospital
    New York Presbyterian HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
  • New York Presbyterian Hospital
    New York Presbyterian HospitalChief Residency, Internal Medicine, 2002 - 2003
  • New York Presbyterian Hospital
    New York Presbyterian HospitalResidency, Internal Medicine, 1999 - 2003
  • New York Presbyterian Hospital
    New York Presbyterian HospitalResidency, Internal Medicine, 2000 - 2002
  • Columbia University Medical Center1999 - 2000
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1999

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2000 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Editorial Board American Journal of Respiratory and Critical Care Medicine, 2013
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Advisory Board POR Masters Degree Program, Irving Institute/Columbia CTSA, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Reply  
    Dinesh Khanna, Elana J Bernstein, David J Lederer, Arthritis & Rheumatology
  • Bidirectional Transfer of Anelloviridae Lineages Between Graft and Host During Lung Transplantation  
    K M Olthoff, J D Christie, D J Lederer, R G Collman, J M Diamond, A Shaked, A R Haas, E Cantu, K Meyer, American journal of transplantation
  • Circulating KL-6, a Biomarker of Lung Injury, in Obstructive Sleep Apnea Disease. Poster Discussion.  
    Lederer DJ, Jelic S, Basner RC, Ishizaka A, Bhattacharya J., American Thoracic Society International Conference
  • Join now to see all

Abstracts/Posters

  • Concurrent measurement of single breath, rebreathe and plethysmographic lung volume in emphysema.
    Milite FM, Lederer DJ, Basner RC, American Thoracic Society, San Francisco, CA
  • Predictors of gas exchange abnormality in emphysema.
    Weingarten JA, Lederer DJ, Milite FM, Basner RC, American Thoracic Society, San Francisco, CA
  • Poverty predicts outcome in pulmonary arterial hypertension.
    Okun J, Lederer DJ, Kawut SM, American Thoracic Society, San Francisco
  • Join now to see all

Lectures

  • Disparities in Solid Organ Transplantation for Ethnic Minoritie. 
    Facts and Solutions Symposium, American Society of Transplantation Symposium, Washington, DC
  • and Ethnic Disparities in Waiting List Outcomes. 
    American College of Chest Physicians, Philadelphia, Pennsylvania
  • Improving Long Term Outcomes after Lung Transplantation: Insights from Clinical, Translational and Basic Research. 
    American Thoracic Society International Meeting, San Diego, California
  • Join now to see all

Press Mentions

  • Workplace Fumes Linked to Signs of Early Lung Disease
    Workplace Fumes Linked to Signs of Early Lung DiseaseAugust 13th, 2017
  • ATS Panel: U.S. Home Oxygen Delivery System Broken
    ATS Panel: U.S. Home Oxygen Delivery System BrokenDecember 13th, 2018
  • RESInsightsLive to Present Online CME Program on the Latest Treatment Options for Idiopathic Pulmonary Fibrosis
    RESInsightsLive to Present Online CME Program on the Latest Treatment Options for Idiopathic Pulmonary FibrosisOctober 23rd, 2015
  • Join now to see all

Grant Support

  • Obesity, Inflammation, and Lung Injury after Lung TransplantationNational Heart Lung and Blood Institute2013–Present
  • Subclinical Interstitial Lung Disease In MESANational Heart, Lung, And Blood Institute2011–2012
  • Explaining Racial And Ethnic Disparities In Idiopathic Pulmonary FibrosisNational Heart, Lung, And Blood Institute2008–2011

Committees

  • Member, American Thoracic Society Document Development & Implementation Committee 2013 - Present
  • Member, ISHLT Lung Transplant Selection Guidelines Working Group
  • Member, Doctoral Admissions Committee, Mailman School of Public Health, Columbia Unviersity

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Consultant/Advisory Board, Gilead